282102-07-2 Usage
Uses
Used in Pharmaceutical Industry:
2-Chloro-4-methoxy-5-nitro-pyrimidine is utilized as an intermediate in the synthesis of various pharmaceuticals. Its unique structure allows it to be a key component in the development of new drugs, contributing to the advancement of medicinal chemistry.
Used in Agrochemical Industry:
In the agrochemical sector, 2-CHLORO-4-METHOXY-5-NITRO-PYRIMIDINE serves as an intermediate in the production of agrochemicals. Its role in this industry is crucial for the synthesis of compounds that can be used in pest control and crop protection, thereby supporting agricultural productivity.
Used in Dye Industry:
2-Chloro-4-methoxy-5-nitro-pyrimidine is also employed in the dye industry, where it acts as an intermediate for the synthesis of dyes. Its chemical properties enable the creation of a variety of dyes with different color characteristics, catering to the diverse needs of various industries.
Used in Organic Synthesis:
As a building block in organic synthesis, 2-CHLORO-4-METHOXY-5-NITRO-PYRIMIDINE is used in the preparation of various biologically active compounds. Its versatility in chemical reactions makes it a valuable component in the synthesis of a wide range of organic compounds with potential applications in various fields.
Check Digit Verification of cas no
The CAS Registry Mumber 282102-07-2 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 2,8,2,1,0 and 2 respectively; the second part has 2 digits, 0 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 282102-07:
(8*2)+(7*8)+(6*2)+(5*1)+(4*0)+(3*2)+(2*0)+(1*7)=102
102 % 10 = 2
So 282102-07-2 is a valid CAS Registry Number.
282102-07-2Relevant academic research and scientific papers
PURINONES AS UBIQUITIN-SPECIFIC PROTEASE 1 INHIBITORS
-
Paragraph 00370, (2017/06/12)
The application relates to inhibitors of USP1 useful in the treatment of cancers, and other USP1 associated diseases and disorders, having the Formula: (I), where R1, R2, R3, R3', R4, R5, X1, X2, X3, X4, and n are described herein.
(5,6-DIHYDRO)PYRIMIDO[4,5-E]INDOLIZINES
-
Page/Page column 38, (2015/11/17)
The invention relates to a compound of Formula (I) wherein, R1 and R2 independently are selected from the group consisting of optionally substituted (6-10C)aryl and (1-5C)heteroaryl groups. The compounds can be used in pharmaceutical compositions, in particular in the treatment of cancer.
ARYLOXYETHYLAMINE COMPOUNDS SUITABLE FOR TREATING DISORDERS THAT RESPOND TO MODULATION OF THE DOPAMINE D3 RECEPTOR
-
Page/Page column 119-120, (2008/06/13)
The present invention relates to aryloxyethylamine compounds of the formula (I) and the physiologically tolerated acid addition salts thereof. The variables have the meanings given in the claims and the description. The invention also relates to the use o
